Disclosure:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

• Akhil Narang, MD, FASE
• Gerard Aurigemma, MD, FASE
• Carlos El-Tallawi
• Nadeen Faza, MD, FASE
• Natalie Edwards, ACS, AMS, PhD, FASE
• Monica Mukherjee, MD, MPH
• Karima Addetia, MD, FASE

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

• Jae Oh, MD, FASE; Anumana (Royalties/Patent Beneficiary); Redniva (Research Funding); Medtronic (Consultant/Advisor)
• Carol Mitchell, PhD, ACS, RDMS, RDCS, RVT, RT(R); Acoustic Range Estimates (Consultant/Advisor); W.L. Gore and Associates (Research Funding)
• Theodore Abraham, MD, FASE; BMS (Research Funding); Cytokinetics (Research Funding); Tenaya Therapeutics (Research Funding); Edgewise Therapeutics (Research Funding)
• Martha Grogan, MD; Alnylam (Consultant/Advisor); BridgeBios/Eidos (Research Funding); AstraZeneca (Consultant/Advisor); NovoNordisk, Intellia, Pfizer, Janssen (Research Funding)
• Jerry Estep, MD, FASE; Abbott (Consultant/Advisor); Procyrion Inc. (Consultant/Advisor); Bioventrix Inc. (Consultant/Advisor)
• Lucy Safi, DO, FASE; Abbott Structural Heart (Speaker/Speaker’s Bureau); Medtronic Structural Heart (Speaker/Speaker’s Bureau)
• G. Burkard Mackenson, MD, PhD, FASE; Philips Healthcare (Research Funding)
• Wendy Tsang, MD, FASE
• Tyler Lamb, MD, MSc, FRCPC, FACC, DRCPSC; Bristol Meyers Squibb (Speaker/Speaker’s Bureau)
• Christiane Haeffele, MD; Edwards Lifesciences (Consultant/Advisor); Stanford University (Consultant/Advisor)
• Jordan Strom, MD, MSc; Edwards Lifesciences (Consultant/Advisor); Ultromics Ltd. (Consultant/Advisor); Heart Sciences (Consultant/Advisor); Bracco Diagnostics; (consulting, grant support); Anumana (grant support); GE Healthcare (consulting, scientific advisory board); Philips Healthcare (grant support, consulting); EchoIQ (grant support, advisory board, stockholder); Pfizer (clinical endpoint committee); EVERSANA (consulting, grant support); Bristol Myers Squibb (consulting); Viz.AI (grant support); Alnylam (scientific advisory board); Ultrasight (scientific advisory. board); Agitated Solutions (clinical endpoint committee)
• Jamie McCabe, MD; Edwards Lifesciences (Consultant/Advisor); Medtronic (Consultant/Advisor); Abbott (Consultant/Advisor); Excision Medical, Excision Medical, Transmural, Arcos, ConKay (Stocks)
• Kiran Belani, MD, FASE, FACC
• Stephen Little, MD, FASE; Abbott Structural (Consultant/Advisor); Medtronic (Consultant/Advisor); Edwards Lifesciences (Consultant/Advisor)
• Partho Sengupta, DM, MBBS, MD, FASE; RCE Technology (Consultant/Advisor); Heart Sciences (Consultant/Advisor)
• Noreen Kelly, MD, MBA; Abbott (Speaker/Speaker's Bureau)
• Dermot Phelan, MD, PhD, FASE; Bristol Myers Squibb (Speaker/Speaker's Bureau); Caption Health (Consultant/Advisor)
• Muhamed Saric, MD, PhD, FASE; Medtronic (Speaker/Speaker's Bureau); Abbott (Speaker/Speaker's Bureau); Boston Scientific (Speaker/Speaker's Bureau)

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.